How to Start a Cold-Chain or Pharmaceutical Logistics Company

Three questions sit under one business name. Which products may you hold? Is the building approved for them? Is the company licensed for the activity? Different bodies answer each.

EDE describes its scope as medical and pharmaceutical products, medical devices and other regulated product groups, and lists registration, market authorisation, pharmacovigilance and inspection among its services. For a logistics company the point is that product regulation does not stop at the manufacturer. Ask EDE and MOHAP which approvals a storage and transport operator needs for the product classes you intend to hold, and whether those depend on the emirate.

For food, Dubai Municipality states that it maintains standards for food and consumer goods through inspections and compliance. Ask the municipality for your site what the food premises requirements are for cold storage and for vehicles.

Write down every product family, its storage range, its owner and its regulator. Frozen, chilled, controlled room temperature and ultra-cold are different operations, and food, medicines and devices are regulated by different bodies. One setpoint for all products is a common mistake, and an inspector reading temperature logs will see it at once.

The matrix also decides what you refuse and which partners carry what. Qualified carriers can move specific product classes. A pharmaceutical operation with its own quality system may need to sit in a different entity from general food logistics, because mixing audit regimes means every customer audits everything. For the customs side of cargo arriving by air or sea, read the guide on a bonded-warehouse or re-export logistics business.

Regulated customers will not wait for a licence. They audit. A pharmaceutical customer expects evidence that the facility was qualified, that temperature was mapped across the space, that monitoring equipment is calibrated, that alarms reach a person who can act, and that vehicles and packaging were qualified for the routes used. Keep this as a file, dated and signed, not as a set of intentions.

Data loggers are not a quality system. The system is the procedures, the training, the change control, the deviation handling and the people who own them. Name the quality role and the responsible person for each regulated product class early, and confirm with EDE or the relevant regulator what the role must hold and where the person must be based. These hires are a cost the licence fee does not show.

Decide the excursion process before a customer asks for it. When a reading leaves its range, who assesses the product, on what data, and who decides whether it can be used? Leave that to the customer in an informal email and a dispute follows. Put the process in the quality agreement.

The entity that signs the quality agreements should own the qualified facility, the monitoring systems and the trained people those agreements assume. Vehicle or property companies can sit elsewhere in the group with genuine roles. The choice between a mainland company and a free-zone licence follows the product flows. Airport-adjacent sites can suit pharmaceutical transit, but facility approval and product permissions follow the goods wherever the building stands, and domestic distribution raises its own questions.

A bank reads this plan as a capital and liability question: costly plant, perishable cargo and losses that arrive in full. Prepare the product and temperature matrix, the facility and vehicle qualification plan, the monitoring and alarm design, the quality agreements and procedures, and the excursion, recall and continuity plans. Show the insurance cover against the values you will hold. Where bank onboarding is the sticking point, the work on corporate bank account readiness covers how the file is built. A coherent file reduces questions. It does not guarantee an account.